GIST SARCOMA LIFE RAFT GROUP CANADA
Charitable organizationCore health care·240 RIDGE WAY · ALLISTON, ON · L9R 0W4·BN 848607024RR0001·website ↗
Last reported: F2024 filing · period ending 2024-06-30
What it does — in its own words
Ongoing programs
Gastrointestinal Stromal Tumour (GIST) is a rare form of sarcoma which is the least known of all the major forms of cancer. GIST can occur anywhere along the GI tract and commonly affects the stomach. Several hundred Canadians are diagnosed with GIST each year. GIST strikes randomly; there are no known risk factors and no known ways to prevent it. However over the last 25+ years research discoveries have advanced the medical community’s understanding of this cancer and have also greatly improved its treatment through targeted therapy drugs. The mission of GIST Sarcoma Life Raft Group… Show more
Gastrointestinal Stromal Tumour (GIST) is a rare form of sarcoma which is the least known of all the major forms of cancer. GIST can occur anywhere along the GI tract and commonly affects the stomach. Several hundred Canadians are diagnosed with GIST each year. GIST strikes randomly; there are no known risk factors and no known ways to prevent it. However over the last 25+ years research discoveries have advanced the medical community’s understanding of this cancer and have also greatly improved its treatment through targeted therapy drugs. The mission of GIST Sarcoma Life Raft Group Canada (LRG Canada) is to ensure the survival of GIST patients to assist patients and caregivers in maximizing the quality of their lives and to support GIST research in Canada. The following ongoing charitable programs support our mission. 1) Support and provide education for GIST patients and caregivers. 2) Provide funding for GIST research in Canada. 3) Sponsor annual patient conferences such as the 'GIST Day of Learning'. 4) Host GIST patient group meetings across Canada. 5) Communicate regularly with GIST patients and caregivers. 6) Maintain a directory of Canadian physicians with expertise in GIST. 7) Increase awareness of GIST among the public and healthcare professionals in Canada. 8) Advocate for access to medical treatment for GIST patients and caregivers across Canada. Since 2015 LRG Canada has helped fund GIST research at the following Canadian research centres - BC Cancer Sunnybrook Research Institute (Toronto) and The Research Institute of the McGill University Health Centre
Program descriptions from its F2024 T3010 filing, verbatim · self-reported · this is also the text our semantic search matches against. source ↗
Tier 1 — what we computed (open data)
From the charity's own F2024 T3010 filing. Self-reported; not independently verified. You can recompute every figure.
Cents to cause
T1 · computed (open data)76¢
Per its F2024 T3010, 76¢ of each dollar spent went to programs.
Sector median: 89¢ across 55,155 computed charities.
T3010 line 5000 ÷ 4950 · Self-reported on the T3010; not independently verified. source ↗
Operating overhead
T1 · computed (open data)24%
Management, administration, and fundraising as a share of total spending. We treat 5–35% as the typical range; we state the figure, you judge.
T3010 line (5010 + 5020) ÷ 4950 · Self-reported on the T3010; not independently verified. source ↗
Reserves
T1 · computed (open data)—
Years current reserves could cover program spending.
Sector quartiles: 0.4 yr / 0.8 yr / 7.5 yr (p25 / median / p90).
T3010 line (4100 + 4140) ÷ 5000 · Self-reported on the T3010; not independently verified. source ↗
Total revenue
T1 · computed (open data)$30K
Last-reported total revenue.
T3010 line 4700 · Self-reported on the T3010; not independently verified. source ↗
Donor-funded
T1 · computed (open data)58%
Share of revenue from receipted donations.
T3010 line 4500 ÷ 4700 · Self-reported on the T3010; not independently verified. source ↗
Government-funded
T1 · computed (open data)0%
Share of revenue from federal, provincial, and municipal sources.
T3010 line 4570 (or 4540+4550+4560) ÷ 4700 · Self-reported on the T3010; not independently verified. source ↗
Over the years
Every figure as filed at each fiscal period end, 2019–2024.
| Period end | Revenue | Cents to cause | Overhead | Reserves |
|---|---|---|---|---|
| 2019-06-30 | $46K | 76¢ | 24% | — |
| 2020-06-30 | $43K | 63¢ | 37% | — |
| 2021-06-30 | $33K | 94¢ | 44% | — |
| 2022-06-30 | $91K | 100¢ | 16% | — |
| 2023-06-30 | $14K | 77¢ | 23% | — |
| 2024-06-30 | $30K | 76¢ | 24% | — |
| trend |
From its T3010 filings (CRA annual releases) · self-reported, not audited by us · when a period is restated in a later release, the newest figures are shown · ✱ = cents-to-cause outside the valid 0–100% range (filing error; not used in rankings). source ↗
★ Tier 2 — Charity Intelligence (analyst-reviewed)
Not rated by Charity Intelligence. Their analysts cover 618 of Canada's 83,761 charities; absence of a rating says nothing about this charity. Our computed figures above stand on their own.
Board of directors
9 directors reported · 7 of 9at arm's length
- Josephy, Philip D.Presidentarm's length
- McLeod, HazelDirectorarm's length
- Nagy, FredDirectorarm's length
- Sullivan, Elliot VDirectornot at arm's length
- Sutherland, Malcolm STreasurerarm's length
- Sullivan, Michelle EDirectornot at arm's length
- Nunnaro, YvonneDirector of Patient Engagementarm's length
- Kirschman, Robert SDirectorarm's length
- Melkonian, GabrielDirectorarm's length
From its F2024T3010 filing (public CRA record), as filed. “Arm's length” means not related to other officials by family or business ties. source ↗
Right of reply
This charity hasn't added a response yet. When it does, it appears here, beside the numbers, and is never removed. Represent this charity? Submit a response.
Verify everything: full public record on CharityData.ca ↗ · CRA charities listing ↗